Xiaocang Cao

3.4k total citations
64 papers, 2.3k citations indexed

About

Xiaocang Cao is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Xiaocang Cao has authored 64 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Genetics and 14 papers in Immunology. Recurrent topics in Xiaocang Cao's work include Gut microbiota and health (15 papers), Inflammatory Bowel Disease (12 papers) and Mesenchymal stem cell research (6 papers). Xiaocang Cao is often cited by papers focused on Gut microbiota and health (15 papers), Inflammatory Bowel Disease (12 papers) and Mesenchymal stem cell research (6 papers). Xiaocang Cao collaborates with scholars based in China, United States and Canada. Xiaocang Cao's co-authors include Bangmao Wang, Hailong Cao, Mengque Xu, Sinan Wang, Weiqiang Wang, Zhongchao Han, Zhibo Han, Meiyu Piao, Yan Fang and Samiullah Khan and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Xiaocang Cao

60 papers receiving 2.3k citations

Peers

Xiaocang Cao
Xiaocang Cao
Citations per year, relative to Xiaocang Cao Xiaocang Cao (= 1×) peers Xiaofeng Li

Countries citing papers authored by Xiaocang Cao

Since Specialization
Citations

This map shows the geographic impact of Xiaocang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaocang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaocang Cao more than expected).

Fields of papers citing papers by Xiaocang Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaocang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaocang Cao. The network helps show where Xiaocang Cao may publish in the future.

Co-authorship network of co-authors of Xiaocang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaocang Cao. A scholar is included among the top collaborators of Xiaocang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaocang Cao. Xiaocang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Sin Man, Wenjing Cao, Xiaocang Cao, et al.. (2025). Multi-omics dissection of metabolic dysregulation associated with immune recovery in people living with HIV-1. Journal of Translational Medicine. 23(1). 143–143. 1 indexed citations
2.
Wang, Ying, Jing Han, Guang Yang, et al.. (2024). Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis. Nature Communications. 15(1). 5874–5874. 5 indexed citations
3.
Wang, Jiewen, Guangbo Kang, Huiying Lu, et al.. (2024). Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities. Clinical and Translational Medicine. 14(3). e1636–e1636. 7 indexed citations
4.
Ye, Yulin, Limin Liu, Xiaocang Cao, & Jingwen Zhao. (2023). Tu1882 BUTYRATE INHIBITS FERROPTOSIS OF M2-LIKE MACROPHAGE BY ACTIVATING NRF2/GPX4 IN RESPONSE TO DEXTRAN SULFATE SODIUMINDUCED EXPERIMENTAL COLITIS. Gastroenterology. 164(6). S–1151. 1 indexed citations
5.
Zhang, Mengfan, et al.. (2023). The C-type lectin COLEC10 is predominantly produced by hepatic stellate cells and involved in the pathogenesis of liver fibrosis. Cell Death and Disease. 14(11). 785–785. 4 indexed citations
6.
Yang, Weili, Xiaoli Wang, Jing Yang, et al.. (2022). Genetic mutation and tumor microbiota determine heterogenicity of tumor immune signature: Evidence from gastric and colorectal synchronous cancers. Frontiers in Immunology. 13. 947080–947080. 8 indexed citations
7.
Sun, Siyuan, Ling Liang, Xiaoli Wang, et al.. (2021). Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota. Frontiers in Immunology. 12. 777665–777665. 159 indexed citations
8.
Li, Li, Kang Chao, Qian Cao, et al.. (2020). Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease. Therapeutic Advances in Gastroenterology. 13. 3974168306–3974168306. 5 indexed citations
9.
Zhao, Tianming, Ya Wang, You Deng, et al.. (2020). Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice. Frontiers in Pharmacology. 11. 463–463. 27 indexed citations
10.
Ma, Chao, et al.. (2020). The clinical value of multimodal ultrasound for the evaluation of disease activity and complications in inflammatory bowel disease. Annals of Palliative Medicine. 9(6). 4146–4155. 11 indexed citations
11.
Zhang, Shuaiqiang, Yuanyuan Liu, Xin Zhang, et al.. (2018). Prostaglandin E2 hydrogel improves cutaneous wound healing via M2 macrophages polarization. Theranostics. 8(19). 5348–5361. 161 indexed citations
12.
Yang, Xue, Yu Gu, Xiaocang Cao, Bangmao Wang, & Hailong Cao. (2018). Smoldering Multiple Myeloma Arising in Ulcerative Colitis. Chinese Medical Journal. 131(21). 2628–2629.
13.
Xie, Runxiang, Yue Sun, Jingyi Wu, et al.. (2018). Maternal High Fat Diet Alters Gut Microbiota of Offspring and Exacerbates DSS-Induced Colitis in Adulthood. Frontiers in Immunology. 9. 2608–2608. 101 indexed citations
14.
Cao, Xiaocang, et al.. (2017). Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research. Frontiers in Cellular and Infection Microbiology. 7. 51–51. 19 indexed citations
15.
Cao, Xiaocang, et al.. (2016). Surgery for ulcerative colitis in the era of biological agents therapy. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 15(12). 1230.
16.
Cao, Hailong, Mengque Xu, Yujie Zhang, et al.. (2014). The secondary bile acid, deoxycholate accelerates intestinal adenoma–adenocarcinoma sequence in Apc min/+ mice through enhancing Wnt signaling. Familial Cancer. 13(4). 563–571. 50 indexed citations
17.
Cao, Xiaocang, Zhibo Han, Hui Zhao, & Qiang Liu. (2014). Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice. The International Journal of Biochemistry & Cell Biology. 53. 372–379. 61 indexed citations
18.
Zhou, Yang, Zhibo Han, Yue Ji, et al.. (2013). CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties. PLoS ONE. 8(3). e59354–e59354. 175 indexed citations
19.
Zhou, Bin, Xiaocang Cao, Zhibo Han, et al.. (2007). Prevention of diabetic microangiopathy by prophylactic transplant of mobilized peripheral blood mononuclear cells. Acta Pharmacologica Sinica. 28(1). 89–97. 15 indexed citations
20.
Zhou, Bin, Xiaocang Cao, Zhibo Han, et al.. (2007). Prevention of diabetic microangiopathy by prophylactic transplant of mobilized peripheral blood mononuclear cells. Acta Pharmacologica Sinica. 28(1). 89–97. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026